Xtalks Life Science Webinars

Indeed, the use of remote administration solutions for COAs is likely only going to increase. Understanding the nuances behind these methods of data collection is vital in the future of clinical research.

TORONTO (PRWEB)
July 07, 2020

As the COVID-19 pandemic spread, research teams worldwide quickly adapted study plans to safely continue research whenever possible. While some observational studies were put on hold entirely, other therapeutic trials were continued with many or all study activities occurring remotely. In some cases, clinical sites were able to remain open with temperature checks, hand washing and social distancing. Where feasible, remote administration of clinical outcomes assessments (COAs) was implemented in order to minimize the loss of data.

What were momentary adaptations have led many clinical trial teams to look longer-term at remote administration options and consider the value of virtual, decentralized, or direct-to-patient clinical trial study designs. Indeed, the use of remote administration solutions for COAs is likely only going to increase. Understanding the nuances behind these methods of data collection is vital in the future of clinical research.

In speaking with sponsors, license holders, technology partners and IRBs, our team has gained many perspectives and will share insights into successful implementation of remote COA administration for both computerized and traditional assessments. In this webinar, the speakers will outline important lessons learned to help guide participants’ teams through remote assessment solutions, as well as specific adaptation options for computerized and conventional assessments.

Join Chris Edgar, PhD, Senior Vice President, Clinical Science, Cogstate, Paul Maruff, PhD, Chief Science Officer, Cogstate, Eric Siemers, MD, Distinguished Medical Adviser, Cogstate and Pamela Ventola, PhD, Senior Science Director, Pediatrics and Rare Disease, Cogstate in a live webinar on Wednesday, July 22, 2020 at 1pm EDT.

For more information or to register for this event, visit Remote Administration Considerations for Conventional and Computerized Clinical Outcome Assessments.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

“NFP remains focused on specialized benefit solutions that address the evolving needs of employers and their employees,” said Shawn Ellis, managing director of NFP Ventures.

NEW YORK (PRWEB)
July 07, 2020

NFP Ventures, the early-stage investment arm of NFP, today announced a strategic investment in Kindbody, the innovative provider of a fertility and family-building solution. The investment, NFP Ventures’ first in a company both founded and fully led by women, includes plans to offer Kindbody’s services to NFP clients so they can integrate the services into employee benefit plan programs.

Kindbody offers end-to-end fertility and family-building services, serving as both a provider and a network solution. Their offering covers fertility treatments, gynecology and LGBTQ+ services, as well as mental health counseling and wellness coaching, to provide one solution from preconception through postpartum. Their approach features direct purchasing and inclusive bundled rates, which allows Kindbody to offer pricing that is up to 30% less than other fertility platforms. NFP clients will have access to Kindbody’s full suite of fertility, wellness, and family-building offerings.

“NFP remains focused on specialized benefit solutions that address the evolving needs of employers and their employees,” said Shawn Ellis, managing director of NFP Ventures. “Kindbody provides affordable fertility services with an exceptional client experience, and is driven by the passion and vision of a stellar female leadership team. We’re excited to partner with them to expand access to family planning assistance.”

“Cost and experience become increasingly important in challenging times and Kindbody’s unique solution addresses these factors directly,” said Mike Goldman, president and chief operating officer of NFP. “We will continue to work with our clients to understand their needs and connect them with innovative solutions – like Kindbody – that help employees overcome a variety of significant challenges.”

“We are thrilled about this investment from NFP Ventures and our plans to maximize the benefits of our partnership for all stakeholders,” said Kindbody cofounder and CEO Gina Bartasi. “NFP’s focus on providing solutions that clients value, creates a path for Kindbody to expand the impact of family planning services and expertise.”

About Kindbody

Kindbody provides fertility, gynecology, and family-building services in modern, tech-enabled clinics and virtually. They are both a provider and a network solution, offering superior results at significantly lower prices, and a reimagined member experience.

About NFP

NFP is a leading insurance broker and consultant providing specialized property and casualty, corporate benefits, retirement and individual solutions through its licensed subsidiaries and affiliates. NFP enables client success through the expertise of over 5,600 global employees, investments in innovative technologies, and enduring relationships with highly rated insurers, vendors, and financial institutions. NFP is the 5th largest benefits broker by global revenue, 6th largest US-based privately owned broker, and 8th best place to work in insurance (Business Insurance); 10th largest property and casualty agency (Insurance Journal); and 13th largest global insurance broker (Best’s Review).

Visit NFP.com to discover how NFP empowers clients to meet their goals.

About NFP Ventures

NFP Venture, LLC (NFP Ventures) is a venture fund launched by NFP that focuses on strategic partnerships and investments in the emerging Insurtech, Fintech and HR Tech arenas. NFP Ventures’ mission is to find, fund and work successfully with visionary executives, providing them with expertise to foster long-term success. Typically, NFP Ventures targets companies seeking Seed to Series B investment that can benefit from NFP’s distribution, human capital and other unique assets to accelerate their growth.

Share article on social media or email:

Compliancy Group

“With the increase in demand for HIPAA compliant apps and software, especially in relation to COVID-19 apps, Compliancy Group saw the need to provide guidance for developers. We believe that taking the concern of compliance out of the equation will greatly improve access to healthcare apps.”

HUNTINGTON, N.Y. (PRWEB)
July 07, 2020

Compliancy Group has developed HIPAA guidance for software developers for developers creating COVID-19 apps. As COVID-19 apps access protected health information (PHI) to function, they are considered business associates under the HIPAA regulation.

Before it is permitted for business associates to create, maintain, store, receive, or transmit PHI, they must first achieve HIPAA compliance. This is why Compliancy Group has developed HIPAA guidance specifically for COVID-19 software developers.

HIPAA compliance for COVID-19 apps requires app developers to ensure the confidentiality, availability, and integrity of PHI is maintained through HIPAA safeguards. Compliancy Group provides all of the resources necessary to enable COVID-19 apps to Achieve, Illustrate, and MaintainTM their HIPAA compliance through our proprietary HIPAA software, the Guard.

Compliancy Group provides clients with guided support to clear up the complexities of HIPAA law. Working with Compliancy Group allows COVID-19 software developers to be confident in their HIPAA compliance program, giving them peace of mind that the leader in HIPAA compliance has them covered.

Compliancy Group Resources:

Downloadable Content:

Free HIPAA Compliance Checklist

Bring Your Own Device (BYOD) Policy

Other:

Privacy and Contact Tracing Apps

Free HIPAA Training

HIPAA News

About Compliancy Group:

HIPAA should be simple. That’s why Compliancy Group is the only HIPAA software with expert Compliance Coaches holding your hand to simplify compliance. Built by auditors, Compliancy Group gives you confidence in your compliance plan to reduce risk, increase patient loyalty, and profitability of your organization.

Why Compliancy Group?

HIPAA Audit Support, no client has ever failed an audit!

Total Compliance Solution

HIPAA Seal of Compliance Verification

Dedicated Compliance Coaches

Visit https://www.compliancy-group.com or call 855.854.4722 to learn how simple compliance can be.

Share article on social media or email:

Dr. Sahar Verdi of Dental Specialists of California

Some patients may have limited amounts of time to get their teeth looking the way they want but skilled dentists will understand how to best accommodate those situations

THOUSAND OAKS, Calif. (PRWEB)
July 06, 2020

A June 8 article on Harper’s Bazaar Arabia reports on a plethora of tips for brides-to-be, and patients in general, who are seeking teeth whitening treatments. The article notes that those wanting optimal results should not wait until right before their big event as the best results generally come from multiple treatments that require a few weeks to achieve their full impact. The article notes that this is not to say that professional teeth whitening treatment won’t offer immediate results – rather, it’s that patients will achieve their best results if they work with their dentist over several visits as this can deliver the right shade across all their teeth as well as a healthy look and feel. Board-certified Periodontist and Cosmetic Dentist Sahar Verdi, D.D.S. of Dental Specialists of California largely agrees, saying that professional-grade teeth whitening treatments vary and that while multiple treatments do have a higher chance of delivering the results that patients ultimately want, patients can sometimes achieve dramatic results with a single treatment. She adds that deciding factors include the skill of the dentist as well as how advanced the treatment is.

Dr. Verdi says that professional teeth whitening often comes in multiple forms, including both in-office and take-home kits. Both options work very well for the majority of patients, she adds, while combining treatments may even further enhance final results. On the topic of patients who may be concerned about how long it takes for a procedure to achieve its maximum impact, such as soon-to-be-brides, Dr. Verdi notes that, provided patients have realistic expectations.

Beyond a dentist’s abilities and access to advanced treatment, Dr. Verdi notes that a patient’s lifestyle and dental care will also play a significant role in how well a whitening treatment may work. Dr. Verdi says that skilled dentists will be able to figure out which approach, or approaches, best suit a patient through careful examination. Even if it turns out that veneers or other prosthetics are necessary, there’s almost always an effective teeth whitening solution for patients and it’s simply up to the dentist to figure out what that is.

Dr. Verdi adds that, regardless of patients’ dental issues or timeframes, there’s always a solution she can provide to ensure all patients can finally get the healthy and beautiful smiles they dream of.

Readers seeking additional information on Dr. Sahar Verdi or Dental Specialists of California can visit her website at https://dentalspecialistsofca.com/ or call her office at (805) 370-7171.

Share article on social media or email:

Dr. David Maine, President & CEO, Mercy Health Services

“Dr. Maine is uniquely qualified to bolster and further expand Mercy’s award-winning clinical programs, enhancing Mercy’s singular position as an independent, Catholic health system with statewide reach,” said Sister Helen Amos, RSM, Executive Chair of the Mercy Health Services Board of Trustees.

BALTIMORE, Md. (PRWEB)
July 06, 2020

David N. Maine, M.D. is the new President & CEO of Mercy Health Services (MHS), effective July 1st, 2020. In January 2020, the Mercy Health Services Board of Trustees named Dr. Maine as Mercy’s future President & CEO following Thomas R. Mullen’s decision to retire after 28 years of successful service. Dr. Maine’s appointment marks the first time a physician has led the hospital and health system in its 145-year history. Mercy Health Services is the parent of Mercy Medical Center, a university-affiliated hospital in Downtown Baltimore founded by the Sisters of Mercy in 1874.

“As a longtime Mercy physician leader, Dr. Maine is uniquely qualified to bolster and further expand Mercy’s award-winning clinical programs, enhancing Mercy’s singular position as an independent, Catholic health system with statewide reach,” said Sister Helen Amos, RSM, Executive Chair of the Mercy Health Services Board of Trustees. “For more than a decade at Mercy, Dr. Maine has consistently demonstrated clinical and business excellence, compassion for our patients, and a deep personal commitment to our mission and values. He’s exactly the right leader at the right time for Mercy.”

“I am honored and humbled to be selected by the Board of Trustees to follow in Tom’s footsteps as President & CEO of Mercy Health Services,” Dr. David Maine said. “As a result of Sister Helen’s and Tom’s leadership over the years, Mercy is blessed with outstanding physicians, providers, nurses, staff and a strong team of executive leaders all committed to moving Mercy forward for many years to come,” Dr. Maine said. “In addition, Mercy has established itself as the premier physician-friendly health system in the region where physicians feel the freedom to practice medicine in the way they know is best for their patients and that has translated to high-quality care with our patients at the center of everything we do.”

“Mercy has become a strong regional health system through the creation of Centers of Excellence led by renowned physicians who developed nationally-recognized clinical programs and by building a large network of high-quality primary and specialty care sites, downtown and around the beltway,” Mr. Mullen said. “The selection of Dr. Maine is a natural extension of Mercy’s physician-driven culture and our mission to serve patients throughout the region within a community of compassionate care. I wish him the very best as he leads Mercy into the future.”

Dr. David Maine, 43, has served as Executive Vice President for Mercy Health Services since October 2019, responsible for all MHS operations, overseeing the Medical Center, specialty and primary care physician networks, and Mercy affiliates. Prior to assuming the Executive Vice President role, he was Executive Vice President of Mercy’s Physician Enterprise, focusing on the growth of its physician network. Dr. Maine has also served as President of Medical Staff; as Senior Vice President of Clinical Transformation, leading Mercy’s efforts to launch the SurgCenter of Towson; and since 2007, as Medical Director of The Center for Interventional Pain Medicine at Mercy, perennially earning distinction as a Baltimore magazine “Top Doctor”.

Dr. Maine lives in Pikesville, Maryland with his wife, also a physician, and their two children. He was born the son of Jewish-Iraqi refugees who fled Iraq for Europe in 1972 due to the ongoing persecution of the religious minority. With the assistance of the Hebrew Immigrant Aid Society, an international refugee aid organization, Dr. Maine’s family eventually immigrated to the United States, settling in Rochester, New York in 1974. (Learn more about Dr. David Maine’s story).

Dr. Maine attended local public schools in Irondequoit, New York. He then matriculated at the University of Rochester School of Arts and Science and the University of Rochester School of Medicine graduating in 2002 with Alpha Omega Alpha honors. He completed his residency in Anesthesiology and his fellowship in Interventional Pain Medicine at The Johns Hopkins Hospital and is Board Certified in Anesthesiology and Pain Medicine.

“With Dr. Maine taking the helm, I have no doubt Mercy will continue its special commitment to the poor and underserved and remain a shining beacon of light and hope for our City,” said Baltimore Archbishop William Lori. “We are grateful for Sister Helen Amos’ continuing service as Executive Chair of the Board of Trustees and Mercy’s ongoing promise to remain an independent, locally-governed health system, fully committed to its Catholic identity.”

“Mercy is well-positioned under the leadership of Dr. David Maine as the new President and CEO to carry forward Mercy’s mission and values as inspired by the life of our founder, Catherine McAuley,” said Sister Pat Coward, RSM, Health Ministry Liaison for the Sisters of Mercy of the Americas, South Central Community. “We look forward to working with Dr. Maine to continue to further our health care ministry for the people of Baltimore.”

Founded in 1874 by the Sisters of Mercy, Mercy Medical Center is a university-affiliated hospital with a national reputation for women’s health care. For more information about Mercy, visit http://www.mdmercy.com and MDMercyMedia on FACEBOOK and TWITTER.

###

Share article on social media or email:

The COVID-19 pandemic has put a spotlight on clinical laboratories in the U.S. and we have vastly increased our coverage of the critical molecular diagnostic segment.

ARLINGTON, Va. (PRWEB)
July 06, 2020

Kalorama Information, part of Science and Medicine Group, announced the release of the latest edition of the Kalorama Clinical Diagnostics MasterFile containing information on more than 42,000 pieces of equipment installed at more than 5,300 hospitals and testing sites facilities in the U.S.

The product is designed to help in vitro diagnostic (IVD) manufacturers find customers, verify the data their sales team are providing, and locate weak points in the competition. Kalorama Clinical Diagnostics MasterFile is the most comprehensive database of the installed base of clinical diagnostic instruments in the U.S. The ongoing survey of hospitals across the country continuously updates data on more than 42,000 instruments, including manufacturer, model, number installed, year installed, and department location. It covers every major modality, including:

• Blood Gas Analyzers
• Chemistry
• Coagulation
• Hematology
• Immunoassay
• Integrated Chem/Immuno
• Mass Spectrometry
• Microbiology AST ID
• Microbiology Blood Culture
• Molecular Diagnostics
• Next-Generation Sequencing
• Urinalysis Analyzers (automated)

Key demographics such as address, population served, budget, and key points of contact are also included. The information provided by laboratory managers at U.S. diagnostic sites is continuously gathered by phone and an online reporting system. Newly added this year is the ability to search based on planned purchases in 2020 providing hundreds of actionable leads.

“The COVID-19 pandemic has put a spotlight on clinical laboratories in the U.S. and we have vastly increased our coverage of the critical molecular diagnostic segment,” said Tamara Smith, VP, Clinical Diagnostics. “Our database can be linked to sources of IDN data so that you can understand the resources of an entire IDN to supplement and verify information collected by your sales team.”

More information is available at: https://kaloramainformation.com/product/clinical-diagnostics-masterfile/

About Science and Medicine Group

Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, healthcare, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Our clients, including some of the top Fortune 500 companies in the world, use our business intelligence, market research and publications, and marketing platforms to grow their businesses globally.

Share article on social media or email:

American Academy of Thermology

“We are excited about having an international panel regarding IR fever detection screening for coronavirus/covid19 during our 2020 Annual Meeting & Scientific Session,” commented Sheri Schwartz, Executive Director of the AAT.

GREENVILLE, S.C. (PRWEB)
July 06, 2020

The American Academy of Thermology (AAT), which is the premiere organization in North America for the scientific development, healthcare training and clinical application of scientific medical infrared imaging, has announced that its 2020 Annual Meeting & Scientific Session has gone VIRTUAL. The session will now go live on September 12 th-13 th, and will also be made available for replay to registered attendees. The Physician’s Medical Thermology Pre-Course will Live Stream on September 11th.

This year’s program will have a dedicated session on the implementation of infrared fever detection screening at airports and other facilities. Speakers will include an international panel of experts from countries including the United States, China, and Brazil. For physicians who want to become trained in interpretation of Medical Thermology studies, a Physician’s Medical Thermology Interpretation pre-course will be held on Friday, September 11th.

Last year’s meeting was a big success. The Physician’s Medical Thermology Interpretation pre-course and the Scientific Session were well attended and everyone felt the learning experience was invaluable.

The 2-day event will feature a keynote address, multiple workshops and case studies, and opportunities for networking at a live, virtual “Meet and Mingle” reception immediately after the Scientific Session on September 12th. Other session topics include neuro-muscuoloskeletal, breast, critical care, and surgical suite applications. In addition, there will be medical residency paper presentations (sponsored by Temple University Hospital). On Sunday, September 13th, there will be a special focus session on Innovations in Medical Infrared thermal imaging.

To register and for more information on the AAT’s 2020 Annual Meeting & Scientific Session, visit https://annualmeeting.aathermology.org. For those with special interest in Infrared Temperature Measurement for Fever Screening navigate to https://courses.aathermology.org/ where FREE training courses are available for Individuals, Businesses and Agencies.

For additional information, interview requests or media inquiries, visit https://aathermology.org/contact, email info(at)aathermology(dot)org or call (864) 236-1073.

About the American Academy of Thermology

Founded in 1971, The American Academy of Thermology (AAT) is the premiere organization in North America for the scientific development, health care training and clinical application of medical infrared imaging. The AAT provides a forum for those who have interest in medically-related conditions that involve the autonomic nervous, peripheral vascular and immuno-inflammatory systems. The organization also holds annual conferences for the presentation of scientific and professional papers, and serves as the voice of its members in medical practice, health care finance, legislative and regulatory related matters.

Share article on social media or email: